CN110897905A - 人参眼部营养精华液及其制备方法 - Google Patents
人参眼部营养精华液及其制备方法 Download PDFInfo
- Publication number
- CN110897905A CN110897905A CN201911042379.1A CN201911042379A CN110897905A CN 110897905 A CN110897905 A CN 110897905A CN 201911042379 A CN201911042379 A CN 201911042379A CN 110897905 A CN110897905 A CN 110897905A
- Authority
- CN
- China
- Prior art keywords
- parts
- ginseng
- vitamin
- extract
- nutrition essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 52
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 51
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 51
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 34
- 230000035764 nutrition Effects 0.000 title claims abstract description 34
- 241000208340 Araliaceae Species 0.000 title claims description 51
- 238000002360 preparation method Methods 0.000 title abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 65
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 60
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 44
- 239000000843 powder Substances 0.000 claims abstract description 39
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 32
- 241000222336 Ganoderma Species 0.000 claims abstract description 31
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 26
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 26
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 23
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 22
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 22
- 235000021014 blueberries Nutrition 0.000 claims abstract description 22
- 229960003080 taurine Drugs 0.000 claims abstract description 22
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 21
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 21
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 21
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 235000009566 rice Nutrition 0.000 claims abstract description 21
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 21
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 21
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 21
- 239000011719 vitamin A Substances 0.000 claims abstract description 21
- 229940045997 vitamin a Drugs 0.000 claims abstract description 21
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 claims abstract description 20
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 20
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 20
- 150000001746 carotenes Chemical class 0.000 claims abstract description 20
- 235000005473 carotenes Nutrition 0.000 claims abstract description 20
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229930003799 tocopherol Natural products 0.000 claims abstract description 20
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 20
- 229960001295 tocopherol Drugs 0.000 claims abstract description 20
- 239000011732 tocopherol Substances 0.000 claims abstract description 20
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000011709 vitamin E Substances 0.000 claims abstract description 20
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 20
- 229940046009 vitamin E Drugs 0.000 claims abstract description 20
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 20
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims abstract description 19
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 19
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims abstract description 19
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 16
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 16
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 16
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 15
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 15
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 13
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 13
- 229960002216 methylparaben Drugs 0.000 claims abstract description 13
- 240000007594 Oryza sativa Species 0.000 claims abstract 5
- 244000293323 Cosmos caudatus Species 0.000 claims description 16
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000003995 emulsifying agent Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 229960005150 glycerol Drugs 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 230000032683 aging Effects 0.000 abstract description 7
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000000686 essence Substances 0.000 description 36
- 210000003491 skin Anatomy 0.000 description 24
- 235000011187 glycerol Nutrition 0.000 description 17
- 241000209094 Oryza Species 0.000 description 16
- 239000011049 pearl Substances 0.000 description 14
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 240000008397 Ganoderma lucidum Species 0.000 description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- -1 sulfate radical Chemical class 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000013142 basic testing Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/985—Skin or skin outgrowth, e.g. hair, nails
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
本发明提供一种人参眼部营养精华液及其制备方法，属于眼部精华液领域。该精华液按照重量份数计，由以下原料组成：人参提取物1‑5份、灵芝提取物1‑5份、人工麝香0.2‑2.5份、珍珠粉3‑8份、薄荷10‑18份、野菊花10‑18份、蓝莓8‑12份、维生素A 4‑12份、胡萝卜素1‑5份、生育酚(维生素E)1‑5份、水解大米蛋白3‑8份、甘油4‑10份、透明质酸钠2‑8份、牛磺酸5‑10份、甘草酸二钾0.5‑3.5份、羟苯甲酯0.2‑2.5份、羟苯乙酯0.5‑3.5份。本发明的精华液具有营养眼部肌肤、缓解眼部衰老、保湿的效果。
Description
技术领域
本发明属于眼部精华液领域，具体涉及一种人参眼部营养精华液及其制备方法。
背景技术
眼部是长时间暴露在空气中的部位，同时又是人体比较脆弱的部门，长时间受到灰尘、雾霾、化妆品的侵袭难免会造成皮肤粗糙、油腻、加速衰老。现有的眼部产品有的对眼部有刺激性，甚至会导致脂肪颗粒的产生，效果不理想。
发明内容
本发明的目的是为了提供一种人参眼部营养精华液及其制备方法，该精华液具有营养眼部肌肤、缓解眼部衰老、保湿的效果。
本发明首先提供一种人参眼部营养精华液，按照重量份数计，由以下原料组成：
人参提取物1-5份、灵芝提取物1-5份、人工麝香0.2-2.5份、珍珠粉3-8份、薄荷10-18份、野菊花10-18份、蓝莓8-12份、维生素A 4-12份、胡萝卜素1-5份、生育酚(维生素E)1-5份、水解大米蛋白3-8份、甘油4-10份、透明质酸钠2-8份、牛磺酸5-10份、甘草酸二钾0.5-3.5份、羟苯甲酯0.2-2.5份、羟苯乙酯0.5-3.5份。
优选的是，所述的人参眼部营养精华液，按照重量份数计，由以下原料组成：
人参提取物2-4份、灵芝提取物2-4份、人工麝香0.5-2份、珍珠粉4-6份、薄荷14-16份、野菊花14-16份、蓝莓9-11份、维生素A 6-10份、胡萝卜素2-4份、生育酚(维生素E)2-4份、水解大米蛋白4-6份、甘油6-8份、透明质酸钠4-6份、牛磺酸6-8份、甘草酸二钾1-3份、羟苯甲酯0.5-2份、羟苯乙酯1-3份。
优选的是，所述的人参眼部营养精华液，按照重量份数计，由以下原料组成：
人参提取物3份、灵芝提取物3份、人工麝香1份、珍珠粉5份、薄荷15份、野菊花15份、蓝莓10份、维生素A8份、胡萝卜素3份、生育酚(维生素E)3份、水解大米蛋白6份、甘油7份、透明质酸钠7份、牛磺酸7份、甘草酸二钾2份、羟苯甲酯1份、羟苯乙酯2份。
本发明还提供一种人参眼部营养精华液的制备方法，包括：
步骤一：将人参和灵芝分别采用高压提取的方法获得人参提取物和灵芝提取物，所述的提取压力为700-720MPa，溶剂为乙醇，料液比为1:15，温度120-125℃，时间为20-25分钟；
步骤二：将薄荷、野菊花加水蒸馏提取，得到蒸馏液；
步骤三：将人工麝香加入乳化剂研磨乳化，然后加入步骤二得到的蒸馏液中；
步骤四：分别将珍珠和蓝莓粉碎，得到珍珠粉和蓝莓粉；
步骤五：将人参提取物、灵芝提取物、珍珠粉、蓝莓粉加入蒸馏液中，搅拌均匀后取上清液；
步骤六：将维生素A、胡萝卜素、生育酚(维生素E)、水解大米蛋白、甘油、透明质酸钠、牛磺酸、甘草酸二钾、羟苯甲酯和羟苯乙酯加入上清液中，混合均匀后过滤，得滤液；
步骤七：将上述滤液进行杀菌，得到人参眼部营养精华液。
优选的是，所述的步骤一提取条件为：提取压力为700MPa，溶剂为乙醇，料液比为1:15，温度120℃，时间为20分钟。
优选的是，所述的步骤三的乳化剂为吐温80。
优选的是，所述的步骤四中的粉碎为将珍珠和蓝莓分别粉碎至300-320目。
优选的是，所述的步骤七杀菌时间为30-40分钟。
本发明中各原料的作用如下：
人参：人参为五加科人参，属植物人参的根，其成份根中含人参皂苷0.4％，人参皂苷A、B、C、D、E和F等，还有多种维生素，多种氨基酸等。它的多种营养素，可增加细胞的活力，延迟衰老，还可抑制黑色素的产生。它的提取液是化妆品中极好的营养添加剂。
灵芝：胶原蛋白和脑酰胺的生成促进，增强了皮肤细胞新陈代谢,结合它的抗氧性，有抗皱抗衰作用；提取物可用作抗炎剂、保湿剂和皮肤美白剂。
人工麝香：含有丰富的营养成份。含水22.66％、灰分8.62％(其中含钾、钠、钙、镁、氯、硫酸根、磷酸根等)、含氯化合物(中含碳酸铵1.1％、铵盐中的氨1.89％。尿素0.4％、氨基酸氮1.077％，总氮量6.16％)、胆甾醇2.19％、粗纤维0.59％、脂肪酸5.15％、麝香酮1.2％。另外麝香是天然香料，属动物性香料之一。
珍珠粉：具有美白、控油、祛痘、去黑头、淡斑、生肌的作用。
薄荷：是一种芳香作物。薄荷具有特殊的芳香、辛辣感和凉感，主要用于牙膏、食品、烟草、酒、清凉饮料、化妆品、香皂的加香。
野菊花：具有抗菌、抗氧化、抗炎等生物活性，应用于化妆品中，可起到预防过敏、保湿、防治粉刺、抗炎和抗衰老等功效。
蓝莓：含有的多种维生素、钙、锌、铁、氨基酸蓝莓、铜都是非常丰富的，这些物质也都是人体所必须的营养物质。另外蓝莓中含有花青素成分可以帮助肌肤抗氧化，有助于防止皮肤产生皱纹，可以让皮肤变得更加有弹性、有光泽。
维生素A：又叫视黄醇，维生素A具有抗衰老功效，能够刺激肌肤底层的胶原蛋白大量产生，改善细纹皱纹，同时对于皮肤塌陷型痘疤也有很好的改善作用。
胡萝卜素：具有防止皮肤干燥，粗糙和有效促进健康及细胞发育的功效。
维生素E：是一种脂溶性维生素，其水解产物为生育酚，是最主要的抗氧化剂之一。具有延缓衰老，有效减少皱纹的产生，保持青春的容貌的作用，同时保护皮肤免受紫外线和污染的伤害，减少疤痕与色素的沉积；加速伤口的愈合。
水解大米蛋白：能够和皮肤产生良好的相容作用，它利于营养物质的渗透，并在皮肤表面形成保护膜。使皮肤光滑细腻，减少皱纹产生。
甘油：一种无色无味的黏性液体，具有保湿锁水的功效。甘油使用后可以在肌肤表面形成一层保护膜，保护肌肤不受空气中的灰尘和杂质的侵害，提高肌肤免疫力，使肌肤长效保持水润。同时美白补水去眼周脂肪粒的作用。
透明质酸钠：是一种透明的胶状体，可瞬间深层保湿、增加皮肤弹性与张力，有助恢复肌肤正常油水平衡，改善干燥及松弛皮肤。
牛磺酸：具有赋活肌肤细胞的能力，可源源不断地提供年轻肌肤快速与持久的能量补充与多重保护。牛磺酸同时也具有提高肌肤免疫力，抵抗外界环境对肌肤的侵袭的功效。
甘草酸二钾：能深入皮肤内部并保持高活性，美白并高效抗氧化。有效抑制黑色素生成过程中多种酶的活性，特别是抑制酪胺酸酵素活性；同时还具有防止皮肤粗糙和抗炎、抗菌的功效。
甘草酸二钾的美白原理：
1、抑制活性氧生成：甘草酸二钾是黄酮类化合物，具有较强的抗氧化活性。有研究者用超氧化物歧化酶SOD作为对照组，结果显示甘草酸二钾可以有效抑制活性氧的生产。
2.抑制酪氨酸酶：和常用的美白原料相比，甘草酸二钾的酪氨酸酶的抑制IC50很低。
3.抑制黑色素生成：选择豚鼠的背部皮肤，在UVB照射下，经0.5％甘草酸二钾预处理的皮肤要比对照组的皮肤白色系数(L值)高，并用作用显著，实验结果显示甘草酸二钾具有显著抑制黑色素生成的作用，可用来用于晒后防止皮肤色素沉着和黑色素生成。
本发明的有益效果
本发明提供一种人参眼部营养精华液及其制备方法，该精华液是由人参提取物、灵芝提取物、珍珠粉、薄荷、野菊花、蓝莓等药材，并加入水解大米蛋白、甘油、透明质酸钠、牛磺酸等，经蒸馏、回流、浓缩、精滤工艺制成，其中人参提取物和灵芝提取物是采用高压提取的方法获得，提取率更高，提取时间短，且提取物更加细腻，利于吸收。本发明的眼部营养精华液具有营养眼部肌肤,缓解眼部衰老和保湿的作用，同时本发明的精华液原料无刺激性。
具体实施方式
为了进一步理解本发明，下面结合具体实施方式对本发明优选实施方案进行描述，但是应当理解，这些描述只是为进一步说明本发明的特征和优点，而不是对本发明权利要求的限制。
本发明首先提供一种人参眼部营养精华液，按照重量份数计，由以下原料组成：
人参提取物1-5份、灵芝提取物1-5份、人工麝香0.2-2.5份、珍珠粉3-8份、薄荷10-18份、野菊花10-18份、蓝莓8-12份、维生素A 4-12份、胡萝卜素1-5份、生育酚(维生素E)1-5份、水解大米蛋白3-8份、甘油4-10份、透明质酸钠2-8份、牛磺酸5-10份、甘草酸二钾0.5-3.5份、羟苯甲酯0.2-2.5份、羟苯乙酯0.5-3.5份。
优选的是，所述的人参眼部营养精华液，按照重量份数计，由以下原料组成：
人参提取物2-4份、灵芝提取物2-4份、人工麝香0.5-2份、珍珠粉4-6份、薄荷14-16份、野菊花14-16份、蓝莓9-11份、维生素A 6-10份、胡萝卜素2-4份、生育酚(维生素E)2-4份、水解大米蛋白4-6份、甘油6-8份、透明质酸钠4-6份、牛磺酸6-8份、甘草酸二钾1-3份、羟苯甲酯0.5-2份、羟苯乙酯1-3份。
更优选的是，所述的人参眼部营养精华液，按照重量份数计，由以下原料组成：
人参提取物3份、灵芝提取物3份、人工麝香1份、珍珠粉5份、薄荷15份、野菊花15份、蓝莓10份、维生素A8份、胡萝卜素3份、生育酚(维生素E)3份、水解大米蛋白6份、甘油7份、透明质酸钠7份、牛磺酸7份、甘草酸二钾2份、羟苯甲酯1份、羟苯乙酯2份。
本发明还提供一种人参眼部营养精华液的制备方法，包括：
步骤一：将人参和灵芝分别采用高压提取的方法获得人参提取物和灵芝提取物，所述的提取压力为700-720MPa，优选为700MPa，溶剂为乙醇，料液比为1:15，温度120-125℃，优选为120℃，时间为20-25分钟，优选为20分钟；
步骤二：将薄荷、野菊花加水蒸馏提取，得到蒸馏液；
步骤三：将人工麝香加入乳化剂研磨乳化，然后加入步骤二得到的蒸馏液中；所述的乳化剂优选为吐温80；
步骤四：分别将珍珠和蓝莓粉碎，优选粉碎至300-320目，得到珍珠粉和蓝莓粉；
步骤五：将人参提取物、灵芝提取物、珍珠粉、蓝莓粉加入蒸馏液中，搅拌均匀后取上清液；
步骤六：将维生素A、胡萝卜素、生育酚(维生素E)、水解大米蛋白、甘油、透明质酸钠、牛磺酸、甘草酸二钾、羟苯甲酯和羟苯乙酯加入上清液中，混合均匀后过滤，得滤液；
步骤七：将上述滤液进行杀菌，所述的杀菌是在高压锅中1.5个大气压，时间优选为30-40分钟，得到人参眼部营养精华液。
下面结合具体实施例对本发明做进一步详细的描述，实施例中涉及到的原料均为商购获得，其中人参提取物和灵芝提取物采用高压提取法获得。
实施例1
一种人参眼部营养精华液，由以下原料组成：
人参提取物2g、灵芝提取物2g、人工麝香0.5g、珍珠粉4g、薄荷14g、野菊花14g、蓝莓9g、维生素A 6g、胡萝卜素2g、生育酚(维生素E)2g、水解大米蛋白4g、甘油6g、透明质酸钠4g、牛磺酸6g、甘草酸二钾1g、羟苯甲酯0.5g、羟苯乙酯1g。
一种人参眼部营养精华液的制备方法，包括：
步骤一：将人参和灵芝分别采用高压提取的方法获得人参提取物和灵芝提取物，所述的提取压力为700MPa，溶剂为乙醇，料液比为1:15，温度为120℃，时间为20分钟；
步骤二：将薄荷、野菊花加水蒸馏提取，得到蒸馏液；
步骤三：将人工麝香加入乳化剂吐温80研磨乳化，然后加入步骤二得到的蒸馏液中；
步骤四：分别将珍珠和蓝莓粉碎至300目，得到珍珠粉和蓝莓粉；
步骤五：将人参提取物、灵芝提取物、珍珠粉、蓝莓粉加入蒸馏液中，搅拌均匀后取上清液；
步骤六：将维生素A、胡萝卜素、生育酚(维生素E)、水解大米蛋白、甘油、透明质酸钠、牛磺酸、甘草酸二钾、羟苯甲酯和羟苯乙酯加入上清液中，混合均匀后过滤，得滤液；
步骤七：将上述滤液进行杀菌，1.5个大气压下，时间为30分钟，得到人参眼部营养精华液。
实施例2
一种人参眼部营养精华液，由以下原料组成：
人参提取物4g、灵芝提取物4g、人工麝香2g、珍珠粉6g、薄荷16g、野菊花16g、蓝莓11g、维生素A10g、胡萝卜素4g、生育酚(维生素E)4g、水解大米蛋白6g、甘油8g、透明质酸钠6g、牛磺酸8g、甘草酸二钾3g、羟苯甲酯2g、羟苯乙酯3g。
一种人参眼部营养精华液的制备方法，包括：
步骤一：将人参和灵芝分别采用高压提取的方法获得人参提取物和灵芝提取物，所述的提取压力为700MPa，溶剂为乙醇，料液比为1:15，温度为120℃，时间为20分钟；
步骤二：将薄荷、野菊花加水蒸馏提取，得到蒸馏液；
步骤三：将人工麝香加入乳化剂吐温80研磨乳化，然后加入步骤二得到的蒸馏液中；
步骤四：分别将珍珠和蓝莓粉碎至300目，得到珍珠粉和蓝莓粉；
步骤五：将人参提取物、灵芝提取物、珍珠粉、蓝莓粉加入蒸馏液中，搅拌均匀后取上清液；
步骤六：将维生素A、胡萝卜素、生育酚(维生素E)、水解大米蛋白、甘油、透明质酸钠、牛磺酸、甘草酸二钾、羟苯甲酯和羟苯乙酯加入上清液中，混合均匀后过滤，得滤液；
步骤七：将上述滤液进行杀菌，1.5个大气压下，时间为30分钟，得到人参眼部营养精华液。
实施例3
一种人参眼部营养精华液，由以下原料组成：
人参提取物3g、灵芝提取物3g、人工麝香1g、珍珠粉5g、薄荷15g、野菊花15g、蓝莓10g、维生素A8g、胡萝卜素3g、生育酚(维生素E)3g、水解大米蛋白6g、甘油7g、透明质酸钠7g、牛磺酸7g、甘草酸二钾2g、羟苯甲酯1g、羟苯乙酯2g。
一种人参眼部营养精华液的制备方法，包括：
步骤一：将人参和灵芝分别采用高压提取的方法获得人参提取物和灵芝提取物，所述的提取压力为700MPa，溶剂为乙醇，料液比为1:15，温度为120℃，时间为20分钟；
步骤二：将薄荷、野菊花加水蒸馏提取，得到蒸馏液；
步骤三：将人工麝香加入乳化剂吐温80研磨乳化，然后加入步骤二得到的蒸馏液中；
步骤四：分别将珍珠和蓝莓粉碎至300目，得到珍珠粉和蓝莓粉；
步骤五：将人参提取物、灵芝提取物、珍珠粉、蓝莓粉加入蒸馏液中，搅拌均匀后取上清液；
步骤六：将维生素A、胡萝卜素、生育酚(维生素E)、水解大米蛋白、甘油、透明质酸钠、牛磺酸、甘草酸二钾、羟苯甲酯和羟苯乙酯加入上清液中，混合均匀后过滤，得滤液；
步骤七：将上述滤液进行杀菌，1.5个大气压下，时间为30分钟，得到人参眼部营养精华液。
对实施例1-3的精华液进行性能检测。
1、实施例1-3的精华液的基础检测如表1所示。
表1 实施例1-3的精华液的性能检测结果
2、抗氧化性测定
将实施例1-3得到的精华液进行抗氧化性测定，结果如表2所示：
| 样品 | 浓度(mg/ml) | DPPH清除率(％) |
| 实施例1 | 5 | 85.3 |
| 实施例2 | 5 | 86.9 |
| 实施例3 | 5 | 90.7 |
表2说明，本发明的眼部营养精华液具有良好的自由基清除能力，表明该精华液具有抗氧化的功效，可以延缓衰老。
3、保湿性能测定
将实施例1-3得到的精华液进行保湿性测定，结果如表3所示：
表3说明，本发明的精华液具有良好的保湿性能。
对所公开的实施例的上述说明，使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的，本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下，在其它实施例中实现。因此，本发明将不会被限制于本文所示的这些实施例，而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (8)
1.一种人参眼部营养精华液，其特征在于，按照重量份数计，由以下原料组成：
人参提取物1-5份、灵芝提取物1-5份、人工麝香0.2-2.5份、珍珠粉3-8份、薄荷10-18份、野菊花10-18份、蓝莓8-12份、维生素A 4-12份、胡萝卜素1-5份、生育酚(维生素E)1-5份、水解大米蛋白3-8份、甘油4-10份、透明质酸钠2-8份、牛磺酸5-10份、甘草酸二钾0.5-3.5份、羟苯甲酯0.2-2.5份、羟苯乙酯0.5-3.5份。
2.根据权利要求1所述的一种人参眼部营养精华液，其特征在于，按照重量份数计，由以下原料组成：
人参提取物2-4份、灵芝提取物2-4份、人工麝香0.5-2份、珍珠粉4-6份、薄荷14-16份、野菊花14-16份、蓝莓9-11份、维生素A 6-10份、胡萝卜素2-4份、生育酚(维生素E)2-4份、水解大米蛋白4-6份、甘油6-8份、透明质酸钠4-6份、牛磺酸6-8份、甘草酸二钾1-3份、羟苯甲酯0.5-2份、羟苯乙酯1-3份。
3.根据权利要求1所述的一种人参眼部营养精华液，其特征在于，按照重量份数计，由以下原料组成：
人参提取物3份、灵芝提取物3份、人工麝香1份、珍珠粉5份、薄荷15份、野菊花15份、蓝莓10份、维生素A8份、胡萝卜素3份、生育酚(维生素E)3份、水解大米蛋白6份、甘油7份、透明质酸钠7份、牛磺酸7份、甘草酸二钾2份、羟苯甲酯1份、羟苯乙酯2份。
4.权利要求1-3任何一项所述的一种人参眼部营养精华液的制备方法，其特征在于，包括：
步骤一：将人参和灵芝分别采用高压提取的方法获得人参提取物和灵芝提取物，所述的提取压力为700-720MPa，溶剂为乙醇，料液比为1:15，温度120-125℃，时间为20-25分钟；
步骤二：将薄荷、野菊花加水蒸馏提取，得到蒸馏液；
步骤三：将人工麝香加入乳化剂研磨乳化，然后加入步骤二得到的蒸馏液中；
步骤四：分别将珍珠和蓝莓粉碎，得到珍珠粉和蓝莓粉；
步骤五：将人参提取物、灵芝提取物、珍珠粉、蓝莓粉加入蒸馏液中，搅拌均匀后取上清液；
步骤六：将维生素A、胡萝卜素、生育酚(维生素E)、水解大米蛋白、甘油、透明质酸钠、牛磺酸、甘草酸二钾、羟苯甲酯和羟苯乙酯加入上清液中，混合均匀后过滤，得滤液；
步骤七：将上述滤液进行杀菌，得到人参眼部营养精华液。
5.根据权利要求4任何一项所述的一种人参眼部营养精华液的制备方法，其特征在于，所述的步骤一提取条件为：提取压力为700MPa，溶剂为乙醇，料液比为1:15，温度120℃，时间为20分钟。
6.根据权利要求4任何一项所述的一种人参眼部营养精华液的制备方法，其特征在于，所述的步骤三的乳化剂为吐温80。
7.根据权利要求4任何一项所述的一种人参眼部营养精华液的制备方法，其特征在于，所述的步骤四中的粉碎为将珍珠和蓝莓分别粉碎至300-320目。
8.根据权利要求4任何一项所述的一种人参眼部营养精华液的制备方法，其特征在于，所述的步骤七杀菌时间为30-40分钟。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911042379.1A CN110897905A (zh) | 2019-10-30 | 2019-10-30 | 人参眼部营养精华液及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911042379.1A CN110897905A (zh) | 2019-10-30 | 2019-10-30 | 人参眼部营养精华液及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110897905A true CN110897905A (zh) | 2020-03-24 |
Family
ID=69815766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911042379.1A Pending CN110897905A (zh) | 2019-10-30 | 2019-10-30 | 人参眼部营养精华液及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110897905A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113975202A (zh) * | 2020-07-26 | 2022-01-28 | 广州元美盛化妆品有限公司 | 一种富含超微分子精华的护肤精华液及制备方法 |
| CN114632053A (zh) * | 2022-04-28 | 2022-06-17 | 浙江长生鸟健康科技股份有限公司 | 珍珠粉增益抗氧化的紫芝粗提物及其发酵方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106389218A (zh) * | 2016-10-28 | 2017-02-15 | 林振慧 | 一种眼部凝露 |
| CN109350588A (zh) * | 2018-11-29 | 2019-02-19 | 珠海大爱科技有限公司 | 一种易吸收、抗衰老、抗辐射眼用组合物及其制备方法 |
-
2019
- 2019-10-30 CN CN201911042379.1A patent/CN110897905A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106389218A (zh) * | 2016-10-28 | 2017-02-15 | 林振慧 | 一种眼部凝露 |
| CN109350588A (zh) * | 2018-11-29 | 2019-02-19 | 珠海大爱科技有限公司 | 一种易吸收、抗衰老、抗辐射眼用组合物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 力神药业（吉林）有限公司: "今明今亮牌眼贴", 《国产非特殊用途化妆品备案信息服务平台》 * |
| 裘炳毅: "《化妆品化学与工艺技术大全》", 31 January 2000, 中国轻工业出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113975202A (zh) * | 2020-07-26 | 2022-01-28 | 广州元美盛化妆品有限公司 | 一种富含超微分子精华的护肤精华液及制备方法 |
| CN114632053A (zh) * | 2022-04-28 | 2022-06-17 | 浙江长生鸟健康科技股份有限公司 | 珍珠粉增益抗氧化的紫芝粗提物及其发酵方法 |
| CN114632053B (zh) * | 2022-04-28 | 2024-02-09 | 浙江长生鸟健康科技股份有限公司 | 珍珠粉增益抗氧化的紫芝粗提物及其发酵方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mellou et al. | Renewable sources: applications in personal care formulations | |
| KR102363238B1 (ko) | 해조류 혼합물을 함유한 피부 보습, 진정, 항산화 및 항염효과를 갖는 화장료 조성물 | |
| CN108113914B (zh) | 一种不添加香精和防腐剂的精华霜及其制备方法 | |
| CN109893464A (zh) | 一种阻断抑制还原黑色素的美白祛斑护肤品及其制备方法 | |
| CN109453087B (zh) | 美白透肌水及其制备方法和美白化妆品添加剂 | |
| CN102973486B (zh) | 一种滋养驻颜洗面奶及其制备方法 | |
| CN109363998B (zh) | 美白化妆品添加剂和美白精华原液及其制备方法 | |
| CN105411931A (zh) | 一种美白化妆品组合物 | |
| CN102908304B (zh) | 一种富含活性多肽的抗衰祛皱化妆水及其制备方法 | |
| CN102091006A (zh) | 一种茶提取物洗面奶及其制备方法 | |
| CN108852972A (zh) | 一种天然护肤精华液及其制备方法 | |
| KR101839013B1 (ko) | 모자반 추출물, 청각 추출물 및 참미역 추출물을 함유하는 화장료 조성물 | |
| CN109453059B (zh) | 美白化妆品添加剂和美白睡眠面膜及其制备方法 | |
| CN109330954B (zh) | 美白亮肤水及其制备方法和酪氨酸酶抑制剂 | |
| US20150182443A1 (en) | Traditional chinese medicine extract composition with whitening skin-care function adn its preparation method | |
| CN115227620B (zh) | 一种滋养保湿亮肤水及其制备方法 | |
| CN108670933A (zh) | 兼具保湿、美白、抗衰老的护肤组合物及其应用 | |
| CN110897905A (zh) | 人参眼部营养精华液及其制备方法 | |
| CN114376960B (zh) | 一种珍珠膏及其制备方法 | |
| CN110801516A (zh) | 一种眼部营养喷雾液及其制备方法 | |
| CN118384056B (zh) | 一种壳聚糖防晒护肤组合物及其制备方法 | |
| KR20230033187A (ko) | 피부 재생을 촉진하는 화장료 조성물 | |
| KR101421537B1 (ko) | 다시마 아임계수 추출물을 유효성분으로 포함하는 화장료 조성물 | |
| CN106727266A (zh) | 一种抗衰老隔离防晒霜及其制备方法 | |
| EP2519223A1 (en) | An agent for stimulating the expression of loxl |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 134000 Tonghua city of Jilin Province Dongchang District left Road No. 1687 Applicant after: Lishen Pharmaceutical (Jilin) Co.,Ltd. Address before: 134000 Tonghua city of Jilin Province Dongchang District left Road No. 1687 Applicant before: TONGHUA LISHEN HEALTH PRODUCTS Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200324 |
|
| WD01 | Invention patent application deemed withdrawn after publication |